Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)

Dominique Valeyre, Carlo Albera, Williamson Bradford, Ulrich Costabel, Talmadge King, Paul Noble, Steven Sahn, Roland du Bois
European Respiratory Journal 2012 40: P3159; DOI:
Dominique Valeyre
1Department of Medicine, Assistance Publique-Hôpitaux, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlo Albera
2Clinical and Biological Sciences, University of Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Williamson Bradford
3Clinical Research, InterMune Inc., Brisbane, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrich Costabel
4Pneumologie/Allergie, Ruhrlandklinik, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Talmadge King
5Department of Medicine, University of California San Francisco, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Noble
6Department of Medicine, Duke University School of Medicine, Durham, NC, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Sahn
7Department of Medicine, Medical University of South Carolina, Charleston, SC, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland du Bois
8Department of Medicine, Imperial College, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. Suppl 56

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online July 25, 2014.

Copyright & Usage 
© 2012 ERS

Author Information

  1. Dominique Valeyre1,
  2. Carlo Albera2,
  3. Williamson Bradford3,
  4. Ulrich Costabel4,
  5. Talmadge King5,
  6. Paul Noble6,
  7. Steven Sahn7 and
  8. Roland du Bois8
  1. 1Department of Medicine, Assistance Publique-Hôpitaux, Paris, France
  2. 2Clinical and Biological Sciences, University of Turin, Italy
  3. 3Clinical Research, InterMune Inc., Brisbane, CA, United States
  4. 4Pneumologie/Allergie, Ruhrlandklinik, Essen, Germany
  5. 5Department of Medicine, University of California San Francisco, CA, United States
  6. 6Department of Medicine, Duke University School of Medicine, Durham, NC, United States
  7. 7Department of Medicine, Medical University of South Carolina, Charleston, SC, United States
  8. 8Department of Medicine, Imperial College, London, United Kingdom

Article usage

Article usage: August 2014 to December 2022

AbstractFullPdf
Aug 2014400
Sep 2014201
Oct 2014402
Nov 2014401
Dec 20141101
Jan 2015801
Feb 2015201
Mar 2015700
Apr 2015103
May 2015602
Jun 2015903
Jul 2015903
Aug 2015601
Sep 2015200
Oct 2015100
Nov 2015002
Dec 2015201
Feb 2016603
Mar 2016605
Jun 2016201
Jul 2016601
Aug 20162012
Sep 2016408
Oct 20166018
Nov 2016306
Dec 2016100
Feb 2017100
Mar 2017601
Apr 2017204
May 2017700
Jun 2017200
Jul 2017502
Aug 2017200
Sep 2017500
Oct 2017100
Nov 2017600
Dec 2017200
Jan 2018601
Mar 2018200
Apr 20181101
May 2018300
Jun 2018400
Jul 2018100
Aug 2018100
Oct 2018302
Dec 2018100
Jan 2019004
Mar 2019001
Apr 2019103
May 2019003
Jun 2019002
Jul 2019402
Aug 2019202
Sep 2019201
Oct 2019203
Nov 2019301
Dec 2019104
Jan 2020302
Feb 2020301
Mar 2020800
Apr 2020800
Jul 2020101
Aug 2020704
Sep 20203900
Oct 20201603
Nov 2020700
Dec 2020300
Jan 2021602
Feb 2021302
Mar 2021300
Apr 2021300
May 2021301
Jun 2021600
Jul 2021700
Aug 20211205
Sep 2021401
Oct 2021703
Nov 202110011
Dec 2021800
Jan 20221804
Feb 2022401
Mar 2022301
Apr 2022503
May 2022102
Jun 2022601
Jul 20221005
Aug 2022505
Sep 2022701
Oct 2022100
Nov 2022103
Dec 2022100

Altmetrics

Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
Dominique Valeyre, Carlo Albera, Williamson Bradford, Ulrich Costabel, Talmadge King, Paul Noble, Steven Sahn, Roland du Bois
European Respiratory Journal Sep 2012, 40 (Suppl 56) P3159;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
Dominique Valeyre, Carlo Albera, Williamson Bradford, Ulrich Costabel, Talmadge King, Paul Noble, Steven Sahn, Roland du Bois
European Respiratory Journal Sep 2012, 40 (Suppl 56) P3159;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
  • Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features
  • Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Show more 1.5 Diffuse Parenchymal Lung Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society